Phase 3 Results

Bharat Biotech Announces Phase 3 Results of COVAXIN® : India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81%

  India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81% · Data from 25,800 participants, received a vaccine or…